BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34442383)

  • 1. High BMI1 Expression with Low CD8+ and CD4+ T Cell Activity Could Promote Breast Cancer Cell Survival: A Machine Learning Approach.
    Chung Y; Min KW; Kim DH; Son BK; Do SI; Chae SW; Kwon MJ
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High PPFIA1 expression promotes cancer survival by suppressing CD8+ T cells in breast cancer: drug discovery and machine learning approach.
    Chu J; Min KW; Kim DH; Son BK; Kim HS; Jung US; Kwon MJ; Do SI
    Breast Cancer; 2023 Mar; 30(2):259-270. PubMed ID: 36478321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach.
    Han MH; Min KW; Noh YK; Kim JM; Cheong JH; Ryu JI; Won YD; Koh SH; Myung JK; Park JY; Kwon MJ
    Cancer Immunol Immunother; 2022 Dec; 71(12):3013-3027. PubMed ID: 35599254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low CDKN1B Expression Associated with Reduced CD8+ T Lymphocytes Predicts Poor Outcome in Breast Cancer in a Machine Learning Analysis.
    Kim HS; Noh YK; Min KW; Kim DH
    J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2 Loss Arising From Tumor-Spread-Through-Air-Spaces (STAS) Promotes Tumor Progression by Suppressing CD8+ T Cells in Lung Adenocarcinoma: A Machine Learning Approach.
    Choi S; Kim HS; Min KW; Noh YK; Lee JY; Moon JY; Jung US; Kwon MJ; Kim DH; Son BK; Pyo JS; Ro SK
    J Korean Med Sci; 2024 Jan; 39(2):e16. PubMed ID: 38225784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
    Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
    BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High WHSC1L1 Expression Reduces Survival Rates in Operated Breast Cancer Patients with Decreased CD8+ T Cells: Machine Learning Approach.
    Kim HS; Min KW; Kim DH; Son BK; Kwon MJ; Hong SM
    J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Associated Fibroblasts Together with a Decline in CD8+ T Cells Predict a Worse Prognosis for Breast Cancer Patients.
    Kim HS; Noh YK; Min KW; Kim DH; Kwon MJ; Pyo JS; Lee JY
    Ann Surg Oncol; 2024 Mar; 31(3):2114-2126. PubMed ID: 38093168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low gamma-butyrobetaine dioxygenase (BBOX1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma: a machine learning approach.
    Kim KS; Moon KM; Min KW; Jung WY; Shin SJ; Lee SW; Kwon MJ; Kim DH; Oh S; Noh YK
    J Pathol Clin Res; 2023 May; 9(3):236-248. PubMed ID: 36864013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
    Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
    Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High KDM1A Expression Associated with Decreased CD8+T Cells Reduces the Breast Cancer Survival Rate in Patients with Breast Cancer.
    Kim HS; Son BK; Kwon MJ; Kim DH; Min KW
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33799951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
    Kim HS; Kim MG; Min KW; Jung US; Kim DH
    PLoS One; 2021; 16(5):e0252052. PubMed ID: 34038440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
    Yin J; Zheng G; Jia X; Zhang Z; Zhang W; Song Y; Xiong Y; He Z
    PLoS One; 2013; 8(9):e73268. PubMed ID: 24039897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis.
    Wu L; Zhang D; Zhou L; Pei Y; Zhuang Y; Cui W; Chen J
    EBioMedicine; 2019 Mar; 41():384-394. PubMed ID: 30803933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
    Srinivasan M; Bharali DJ; Sudha T; Khedr M; Guest I; Sell S; Glinsky GV; Mousa SA
    Oncotarget; 2017 Jun; 8(24):38731-38742. PubMed ID: 28418883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells.
    Chen SM; Wang BY; Lee CH; Lee HT; Li JJ; Hong GC; Hung YC; Chien PJ; Chang CY; Hsu LS; Chang WW
    Oncotarget; 2017 Sep; 8(44):76057-76068. PubMed ID: 29100291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    M JR; S V
    Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
    Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
    Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.